HKPD
Cellyan Biotechnology Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · HK
$0.13
−8.86%Leverage
- Debt / equity
- 0.13x
- Net debt / equity
- 0.11x
- Debt / assets
- 0.10x
- Debt / EBITDA
- -1.93x
- Net debt / EBITDA
- -1.59x
Liquidity & coverage
- Current ratio
- 3.86x
- Quick ratio
- 3.75x
- Cash ratio
- 0.07x
- Interest coverage
- -3.76x
- EBITDA / interest
- -2.84x
- Working capital
- $9.1M
Cash & dividend
- FCF / debt
- -0.23x
- Cash flow / debt
- -0.14x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026